Peptides and the Regulatory Landscape: Where Things Stand and What's Ahead
- Thread starter Chili777
- Start date
lessthanhalf
Explorer
I don't live in the US, yet whatever goes on over there ripples out to the rest of us, like it or not. There's a solid piece that lays out part of how their system works — before reading it, none of it added up; even now it's still fairly illogical, but at least I understand a bit more of it.
Over in Aus things are far less complicated: everything is banned, though enforcement is pretty lax.
Over in Aus things are far less complicated: everything is banned, though enforcement is pretty lax.
"State laws cannot permit what federal law prohibits." If U.S. states are able to grant licenses to brick-and-mortar shops to sell cannabis—banned at the federal level—for recreational purposes with no prescription needed, then why couldn't they take the same approach with peptides (presuming in-state API manufacturing)?
On a related side note, a friend's top hypothesis regarding what "feinereich" is doing is that they are carrying out venture-capital due diligence, aiming to buy out or replicate successful grey-market suppliers ahead of potential shifts (503C and further, as the article suggests) that may not only be on the horizon but that they would actively push for. That would account for their focus on domestic, single-vial suppliers and domestic labs, plus the dollar figures that strike us non-VC ordinary folks as absurd.
On a related side note, a friend's top hypothesis regarding what "feinereich" is doing is that they are carrying out venture-capital due diligence, aiming to buy out or replicate successful grey-market suppliers ahead of potential shifts (503C and further, as the article suggests) that may not only be on the horizon but that they would actively push for. That would account for their focus on domestic, single-vial suppliers and domestic labs, plus the dollar figures that strike us non-VC ordinary folks as absurd.
Where I live, legalizing MJ came about through a referendum that got placed on the ballot as a question. Voters approved it. Getting peptides to that same critical mass would be an extremely difficult undertaking. On top of that, Big Pharma is eyeing these compounds for monetization in the style of SS-31, TA-1 and Tesamorelin, and in Congress money is the one thing that works 100% of the time.
FarmgirlRebel
Explorer
That right there...! The whole profit angle.
Suppose they modify the peptide only slightly, enough that a patent becomes possible...though I question whether that would carry over to grey market peptides, since from what I understand, getting a patent on them is notoriously hard because they occur naturally in the human body.
Honestly, in this area I am not a fan of government regulation...I realize not everyone will agree, but come on, if you are purchasing from a vendor overseas and injecting a product that lacks FDA approval, my guess is that most of those people would not support the government restricting access. I doubt that happens in the near term, but the larger RUO GLP vendors could become a target.